Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-06-07 Purchase | 2022-06-09 06:00 am | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T President and Chief Executive | 20,000 | $1.37 | $27,400 | 777,317 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-15 Option Award | 2024-05-17 4:00 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 1,806 | $1.683 | 34,987 (Direct) | View |
2024-02-19 Option Award | 2024-02-21 4:56 pm | N/A 2034-02-18 | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 80,000 | $0 | 80,000 (Direct) | View |
2023-11-15 Option Award | 2023-11-16 5:30 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 5,979 | $0.4973 | 829,543 (Direct) | View |
2023-08-11 Exercise | 2023-08-14 08:00 am | N/A 2023-12-16 | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 33,799 | $0 | 823,564 (Direct) | View |
2023-08-11 Exercise | 2023-08-14 08:00 am | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 33,799 | $0.52 | 823,564 (Direct) | View |
2023-05-15 Option Award | 2023-05-16 08:03 am | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 6,401 | $0.459 | 789,765 (Direct) | View |
2023-04-19 Option Award | 2023-04-21 8:41 pm | N/A 2033-04-18 | Tracon Pharmaceuticals Inc. | TCON | WORLAND STEPHEN T Director | 18,000 | $0 | 18,000 (Direct) | View |
2023-01-17 Option Award | 2023-01-19 5:10 pm | N/A 2033-01-16 | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 1,000,000 | $0 | 1,000,000 (Direct) | View |
2022-11-15 Option Award | 2022-11-16 6:27 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T Chief Executive Officer | 6,047 | $0.4684 | 783,364 (Direct) | View |
2022-06-20 Option Award | 2022-06-22 4:13 pm | N/A 2032-06-19 | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T President and Chief Executive | 520,674 | $0 | 520,674 (Direct) | View |
2022-06-14 Option Award | 2022-06-16 9:36 pm | N/A 2032-06-13 | Tracon Pharmaceuticals Inc. | TCON | WORLAND STEPHEN T Director | 15,750 | $0 | 15,750 (Direct) | View |
2022-05-13 Option Award | 2022-05-17 8:44 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T President and Chief Executive | 1,837 | $1.53 | 757,317 (Direct) | View |
2022-01-20 Option Award | 2022-01-24 8:04 pm | N/A 2032-01-19 | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T President and Chief Executive | 520,674 | $0 | 520,674 (Direct) | View |
2021-08-25 Option Award | 2021-08-27 5:54 pm | N/A 2023-12-16 | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T President and Chief Executive | 2,306,260 | $0 | 2,918,599 (Direct) | View |
2021-08-25 Option Award | 2021-08-27 5:54 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | WORLAND STEPHEN T President and Chief Executive | 50,000 | $10 | 2,918,599 (Indirect) | View |
2021-06-10 Option Award | 2021-06-24 7:00 pm | N/A 2031-06-09 | Tracon Pharmaceuticals Inc. | TCON | WORLAND STEPHEN T Director | 10,500 | $0 | 10,500 (Direct) | View |
2020-06-10 Option Award | 2020-06-16 5:29 pm | N/A 2030-06-09 | Tracon Pharmaceuticals Inc. | TCON | WORLAND STEPHEN T Director | 4,500 | $0 | 4,500 (Direct) | View |